116 related articles for article (PubMed ID: 38199596)
21. FAM107A as a tumor suppressor in esophageal squamous carcinoma inhibits growth and metastasis.
Zhang J; Di S; Li M; Dong Y; Xie S; Gong T; Hu P; Jia Q; Fan B
Pathol Res Pract; 2023 Dec; 252():154945. PubMed ID: 37977035
[TBL] [Abstract][Full Text] [Related]
22. Long noncoding RNA RP11-766N7.4 functions as a tumor suppressor by regulating epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Yao GL; Pan CF; Xu H; Wei K; Liu B; Zhai R; Chen YJ
Biomed Pharmacother; 2017 Apr; 88():778-785. PubMed ID: 28157654
[TBL] [Abstract][Full Text] [Related]
23. miR-25 mediates metastasis and epithelial-mesenchymal-transition in human esophageal squamous cell carcinoma via regulation of E-cadherin signaling.
Liu B; Li X; Li C; Xu R; Sun X
Bioengineered; 2019 Dec; 10(1):679-688. PubMed ID: 31679450
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
25. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
[TBL] [Abstract][Full Text] [Related]
26. LTBP1 promotes esophageal squamous cell carcinoma progression through epithelial-mesenchymal transition and cancer-associated fibroblasts transformation.
Cai R; Wang P; Zhao X; Lu X; Deng R; Wang X; Su Z; Hong C; Lin J
J Transl Med; 2020 Mar; 18(1):139. PubMed ID: 32216815
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition.
Cui F; Wu D; He X; Wang W; Xi J; Wang M
Tumour Biol; 2016 Aug; 37(8):10871-6. PubMed ID: 26883252
[TBL] [Abstract][Full Text] [Related]
28. Hsa_circ_0006948 enhances cancer progression and epithelial-mesenchymal transition through the miR-490-3p/HMGA2 axis in esophageal squamous cell carcinoma.
Pan Z; Lin J; Wu D; He X; Wang W; Hu X; Zhang L; Wang M
Aging (Albany NY); 2019 Dec; 11(24):11937-11954. PubMed ID: 31881015
[TBL] [Abstract][Full Text] [Related]
29. RASSF10 exhibits tumor‑suppressing potential involving tumor proliferation, metastasis and epithelial‑mesenchymal transition in esophageal squamous cell carcinoma.
Liu Y; Zhu X; Zhang W; Bian T; Wu Z; Zhang J; Qiu H; Hu Y; Feng J; Shi J
Oncol Rep; 2022 Apr; 47(4):. PubMed ID: 35211758
[TBL] [Abstract][Full Text] [Related]
30. Aberrant NSG1 Expression Promotes Esophageal Squamous Cell Carcinoma Cell EMT by the Activation of ERK Signaling Pathway.
Lin X; Tu M; Zhang Y; Zhuang W; Cai L; Zhang L; Yu L; Zhang Z; Huang Y
Dig Dis Sci; 2023 May; 68(5):1847-1857. PubMed ID: 36396779
[TBL] [Abstract][Full Text] [Related]
31. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
[TBL] [Abstract][Full Text] [Related]
32. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
[TBL] [Abstract][Full Text] [Related]
33. DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway.
Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y
Int J Oncol; 2020 May; 56(5):1115-1128. PubMed ID: 32319588
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition.
Zhang CY; Li RK; Qi Y; Li XN; Yang Y; Liu DL; Zhao J; Zhu DY; Wu K; Zhou XD; Zhao S
Cell Biol Toxicol; 2016 Oct; 32(5):391-401. PubMed ID: 27250657
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.
Yue Y; Lian J; Wang T; Luo C; Yuan Y; Qin G; Zhang B; Zhang Y
Cancer Sci; 2020 Mar; 111(3):795-806. PubMed ID: 31883400
[TBL] [Abstract][Full Text] [Related]
36. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
37. LncRNA DDX11 antisense RNA 1 promotes EMT process of esophageal squamous cell carcinoma by sponging miR-30d-5p to regulate SNAI1/ZEB2 expression and Wnt/β-catenin pathway.
Guo Y; Sun P; Guo W; Yin Q; Han J; Sheng S; Liang J; Dong Z
Bioengineered; 2021 Dec; 12(2):11425-11440. PubMed ID: 34866524
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-30c functions as a tumor suppressor via targeting SNAI1 in esophageal squamous cell carcinoma.
Ma T; Zhao Y; Lu Q; Lu Y; Liu Z; Xue T; Shao Y
Biomed Pharmacother; 2018 Feb; 98():680-686. PubMed ID: 29304493
[TBL] [Abstract][Full Text] [Related]
39. Single-cell transcriptomic analysis reveals the landscape of epithelial-mesenchymal transition molecular heterogeneity in esophageal squamous cell carcinoma.
Guo D; Sheng K; Zhang Q; Li P; Sun H; Wang Y; Lyu X; Jia Y; Wang C; Wu J; Zhang X; Wang D; Sun Y; Huang S; Yu J; Zhang J
Cancer Lett; 2024 Apr; 587():216723. PubMed ID: 38342234
[TBL] [Abstract][Full Text] [Related]
40. MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT.
Wang F; Wang J; Yang X; Chen D; Wang L
Diagn Pathol; 2016 Sep; 11(1):88. PubMed ID: 27628042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
